Gabriele Greve

PhD Student

University Freiburg Medical Centre
Department of Medicine, Div. of Haematology and Oncology

2017 PhD thesis, Albert-Ludwigs-University of Freiburg
2010 - 2017 PhD student in the lab of Prof. Dr. Michel Lübbert, Division of Haematology and Oncology, University Freiburg Medical Centre
2010 Diploma thesis in Molecular Biology and Genetics, Albert-Ludwigs-University of Freiburg
2001 - 2010 Study of Biology, Albert-Ludwigs-University of Freiburg


  • Blum S., Greve G. and Lubbert M. (2017) Innovative strategies for adverse karyotype acute myeloid leukemia. Curr Opin Hematol 24, 89-98.
  • Schiffmann I., Greve G., Jung M. and Lubbert M. (2016) Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives. Epigenetics 11, 858-870.
  • Greve G., Schiffmann I., Pfeifer D., Pantic M., Schuler J. and Lubbert M. (2015) The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells. BMC Cancer 15, 947.
  • Greve G., Schiffmann I. and Lubbert M. (2015) Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid. J Cancer Res Clin Oncol 141, 2171-2180.